Slope is honored to host the Biospecimen Management Consortium (BMC) an industry-led consortium with the shared objective of driving sample excellence in clinical research. Founding members include GRAIL, GSK, ILiAD Biotechnologies, LLC, Moderna, Novartis, Roche, Takeda, and Teal Health. We commend these organizations for joining together to set standards, streamline operations and data, and shape regulatory policy. To read the full press release, view here: https://lnkd.in/gKxTBBRp #BiospecimenConsortium #BiospecimenManagement #ClinicalTrials
Amazing, congrats!
Exciting news!
Excited to see this consortium come together!